Nasal production of IL-26 involving T cells in smokers with and without chronic obstructive pulmonary disease
Journal of Allergy and Clinical Immunology · 2025
DOI: 10.1016/j.jaci.2025.03.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Julia Arebro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ear, Nose, and Throat (ENT) Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Swed…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Interleukins, Smoking, Nasal Mucosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Hjärt-Lungfonden.
Themen: COPD
Abstract (Originalsprache)
BACKGROUND: Novel specific therapy in chronic obstructive pulmonary disease (COPD) will require accessible targets for endotyping to identify responsive patients. It is therefore of interest that IL-26 in the bronchoalveolar space is enhanced and associates with bronchoalveolar pathology among long-term smokers (LTS) with and without COPD. OBJECTIVE: We determined whether IL-26 in the nasal cavity can be produced by T cells and associates with bronchoalveolar pathology and clinical symptoms in LTS with and without COPD. METHODS: We characterized LTS with and without COPD plus healthy nonsmokers by radiology, spirometry, modified Medical Research Council scale, and St George Respiratory Questionnaire. We determined extracellular IL-26 concentrations (via ELISA) in nasal (NAL) and bronchoalveolar lavage (BAL) samples, BAL neutrophil counts, and NAL IL-26+ T-cell expression (via flow cytometry). RESULTS: The NAL IL-26 concentrations were higher in LTS with COPD than in healthy nonsmokers. These enhanced IL-26 concentrations displayed a positive correlation with forced expiratory volume in 1 second/forced vital capacity ratio. The IL-26 protein was expressed in CD4+ and CD8+ T cells, but only a small portion of these cells coexpressed IL-15, IL-17A, or IL-22 in LTS with COPD. In this group, IL-26+ CD3+ T cells displayed a negative correlation with forced expiratory volume in 1 second, as did with extracellular NAL IL-26 concentrations. The relative mean fluorescence intensity for CD8+ T cells displayed a negative correlation with modified Medical Research Council and St George Respiratory Questionnaire score. CONCLUSION: In the nasal cavity, IL-26 can be produced by local T cells. This IL-26 reflects bronchoalveolar pathology and clinical symptoms, thereby constituting an accessible target with potential for clinically relevant endotyping in COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Ear, Nose, and Throat (ENT) Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of ENT Diseases, Karolinska University Hospital, Stockh…
- Division for Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska Severe COPD Center, Karolinska University…
- Division for Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Division of Ear, Nose, and Throat (ENT) Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Division for Lung and Airway Research, Institute of Environmental…
- Division for Immunology and Respiratory Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Division of Radiology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Radiology, Karolinska University Hospital, Stockholm, Sweden.
Förderung
- Vetenskapsrådet
- Hjärt-Lungfonden
Zitieren
APA
Arebro, J., Pournaras, N., Ramos-Ramírez, P., Cardenas, E. I., Bandeira, E., Che, K. F., Brundin, B., Bossios, A., Karimi, R., Nyrén, S., Stjärne, P., Sköld, M., & Lindén, A. (2025). Nasal production of IL-26 involving T cells in smokers with and without chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.03.017
Vancouver
Arebro J, Pournaras N, Ramos-Ramírez P, Cardenas EI, Bandeira E, Che KF, et al. Nasal production of IL-26 involving T cells in smokers with and without chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.03.017
BibTeX
@article{Arebro2025,
author = {Arebro, Julia and Pournaras, Nikolaos and Ramos-Ramírez, Patricia and Cardenas, Eduardo I and Bandeira, Elga and Che, Karlhans Fru and Brundin, Bettina and Bossios, Apostolos and Karimi, Reza and Nyrén, Sven and Stjärne, Pär and Sköld, Magnus and Lindén, Anders},
title = {Nasal production of IL-26 involving T cells in smokers with and without chronic obstructive pulmonary disease},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
doi = {10.1016/j.jaci.2025.03.017}
}
EUVIMED